Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites

Magnetic Resonance in Medicine

Volumn 60, Issue 4, 2008, Pages 964-969

  Mullins, Paul Gerald ^a,b   Chen, Hongji ^b   Xu, Jing ^b   Caprihan, Arvind ^b   Gasparovic, Charles ^b,c  

^a BANGOR UNIVERSITY   (United Kingdom)

^b MIND RESEARCH NETWORK   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

1H MRS; Brain; GABA; Glutamate; J coupled metabolites; Reliability; Spectroscopy

Indexed keywords

AMINO ACIDS; BIOMOLECULES; BRAIN; FREQUENCY STANDARDS; MAGNETIC RESONANCE; METABOLITES; MODULATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RELIABILITY; SPECTROSCOPY;

COEFFICIENTS OF VARIATIONS; GABA; GLUTAMATE; J-COUPLED METABOLITES; MODULATION EFFECTS; N-ACETYL ASPARTATE; POINT RESOLVED SPECTROSCOPIES; ^1H-MRS;

PRESSES (MACHINE TOOLS);

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; N ACETYLASPARTIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; AMINO ACID BRAIN LEVEL; ARTICLE; BRAIN; BRAIN LEVEL; CINGULATE GYRUS; CLINICAL ARTICLE; HUMAN; INTERMETHOD COMPARISON; METABOLITE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RELIABILITY; TECHNIQUE;

EID: 53549083275     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21696     Document Type: Article

References (34)

1. De Witte P. Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict Behav 2004;29:1325-1339.
2. De Witte P, Pinto E, Ansseau M, Verbanck P. Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 2003;27:189-197.
3. Rowland L, Bustillo JR, Lauriello J. Proton magnetic resonance spectroscopy (1H-MRS) studies of schizophrenia. Semin Clin Neuropsychiatry 2001;6:121-130.
4. Rowland L, Mullins P, Jung R, Lenroot R, Lauriello J, Brooks W, Bustillo J. Neurochemistry in chronic schizophrenia: a 4T-proton magnetic resonance spectroscopy study. Schizophr Res 2003;60:245.
5. Theberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 2003;160:2231-2233.
6. Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, Neufeld RW, Rogers J, Pavlosky W, Schaefer B, Densmore M, Al-Semaan Y, Williamson PC. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 2002;159:1944-1946.
7. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 2002;43:703-710.
8. Simister RJ, Woermann FG, McLean MA, Bartlett PA, Barker GJ, Duncan JS. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia 2002;43:1021-1031.
9. Mattson M. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 2003;3:65-94.
10. Mullins P, Rowland L, Jung R, Sibbitt W. A novel technique to study the brain's response to pain: proton magnetic resonance spectroscopy. Neuroimage 2005;26:642-646.
11. Mangia S, Tkac I, Gruetter R, Van de Moortele PF, Maraviglia B, Ugurbil K. Sustained neuronal activation raises oxidative metabolism to a new steady-state level: evidence from 1H NMR spectroscopy in the human visual cortex. J Cereb Blood Flow Metab 2007;27:1055-1063.
12. Rowland L, Bustillo J, Mullins P, Jung R, Lenroot R, Landgraf E, Barrow R, Yeo R, Lauriello J, Brooks W. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry 2005;162:394-396.
13. Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001;265:54-84.
14. Brooks WM, Friedman SD, Stidley CA. Reproducibility of 1H-MRS in vivo. Magn Reson Med 1999;41:193-197.
15. Mullins P, Rowland L, Bustillo J, Bedrick E, Lauriello J, Brooks W. Reproducibility of 1H-MRS measurements in schizophrenic patients. Magn Reson Med 2003;50:704-707.
16. Thompson RB, Allen PS. A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: its application to glutamate. Magn Reson Med 1998;39:762-771.
17. Dreher W, Leibfritz D. Detection of homonuclear decoupled in vivo proton NMR spectra using constant time chemical shift encoding: CT-PRESS. Magn Reson Imaging 1999;17:141-150.
18. Mayer D, Spielman D. Detection of glutamate in the human brain at 3 T using optimized constant time point resolved spectroscopy. Magn Reson Med 2005;54:439-442.
19. Hurd R, Sailasuta N, Srinivasan R, Vigneron D, Pelletier D, Nelson S. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med 2004;51:435-440.
20. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004;21:1762-1771.
21. Hu J, Yang S, Xuan Y, Jiang Q, Yang Y, Haacke E. Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T. J Magn Reson 2007;185:204-213.
22. Jang D, Lee J, Lee E, Park S, Kim J, Namkoong K, Yoon K, Kim I, Kim S. Interindividual reproducibility of glutamate quantification using 1.5-T proton magnetic resonance spectroscopy. Magn Reson Med 2005;53:708-712.
23. Choi C, Coupland N, Bhardwaj P, Kalra S, Casault C, Reid K, Allen P. T2 measurement and quantification of glutamate in human brain in vivo. Magn Reson Med 2006;56:971-977.
24. Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D. Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed 2005;18:1-13.
25. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. Magma 2001;12:141-152.
26. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-264.
27. Gasparovic C, Song T, Devier D, Bockholt H, Caprihan A, Mullins P, Posse S, Jung R, Morrison L. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 2006;55:1219-1226.
28. Traber F, Block W, Lamerichs R, Gieseke J, Schild HH. IH metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004;19:537-545.
29. Mlynarik V, Gruber S, Moser E. Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed 2001;14:325-331.
30. Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W, Ludolph A, Klose U. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med 2003;50:1296-1301.
31. Mayer D, Kim D, Adalsteinsson E, Spielman D. Fast CT-PRESS-based spiral chemical shift imaging at 3 Tesla. Magn Reson Med 2006;55:974-978.
32. Lymer K, Haga K, Marshall I, Sailasuta N, Wardlaw J. Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy. Magn Reson Imaging 2007;25:634-640.
33. Schulte RF, Boesiger P. ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed 2006;19:255-263.
34. Velan SS, Lemieux SK, Raylman RR, Boling W, Hobbs GR, Spencer RG, Sridhar R, Kuppusamy P, Thomas MA. Detection of cerebral metabolites by single-voxel-based PRESS and COSY techniques at 3T. J Magn Reson Imaging 2007;26:405-409.